Trial site
Melita Medical Sp. z o.o.
- 27running trials
- 10closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis18 trials
- Crohn's disease15 trials
- Chronic spontaneous urticaria2 trials
- Coeliac disease2 trials
- COPD1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Hidradenitis suppurativa1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 221 trials
- Phase 313 trials
- Phase 2/32 trials
- Phase 42 trials
- Status
- Active, not recruiting14 trials
- Recruiting12 trials
- Completed10 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Merck Sharp & Dohme LLC4 trials
- Amgen Inc.2 trials
- Hoffmann-La Roche2 trials
- Janssen-Cilag Ltd.2 trials
- and 19 more
Running trials
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Recruiting
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease6 recruiting
- Ulcerative colitis6 recruiting
- Chronic spontaneous urticaria1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
Closed trials
Completed
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Completed
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026